|
WTAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.371350E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.844400E-02 |
| Normal-vs-Stage2 |
9.383200E-01 |
| Normal-vs-Stage3 |
8.795000E-01 |
| Normal-vs-Stage4 |
8.015200E-01 |
| Stage1-vs-Stage2 |
1.803440E-01 |
| Stage1-vs-Stage3 |
1.951790E-01 |
| Stage1-vs-Stage4 |
4.445200E-01 |
| Stage2-vs-Stage3 |
8.575600E-01 |
| Stage2-vs-Stage4 |
8.307000E-01 |
| Stage3-vs-Stage4 |
9.350400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.387650E-01 |
| Normal-vs-AfricanAmerican |
3.641400E-01 |
| Normal-vs-Asian |
3.710300E-02 |
| Caucasian-vs-AfricanAmerican |
7.039400E-01 |
| Caucasian-vs-Asian |
3.646600E-01 |
| AfricanAmerican-vs-Asian |
2.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.922100E-02 |
| Normal-vs-Female |
9.932000E-01 |
| Male-vs-Female |
9.090400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.822040E-01 |
| Normal-vs-Extreme_Weight |
3.390100E-02 |
| Normal-vs-Obese |
4.666200E-01 |
| Normal-vs-Extreme_Obese |
2.535600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.729400E-01 |
| Normal_Weight-vs-Obese |
5.015200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.354400E-01 |
| Extreme_Weight-vs-Obese |
1.674770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.467600E-01 |
| Obese-vs-Extreme_Obese |
1.696950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.746800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.517000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.225800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.878000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.824400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.159980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.281600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.933370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.526420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.441200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.772400E-02 |
| Normal-VS-Type2 PRCC |
1.400770E-01 |
| Normal-VS-KIRP CIMP |
1.631560E-02 |
| Normal-VS-Unclassified PRCC |
2.228600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.590800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.058000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.783800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.672330E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.886400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.617600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.110160E-01 |
| Normal-vs-N1 |
2.195400E-01 |
| Normal-vs-N2 |
2.279700E-02 |
| N0-vs-N1 |
2.426200E-02 |
| N0-vs-N2 |
9.845400E-01 |
| N1-vs-N2 |
2.044100E-02 |
|
|
